-
The FDA has approved the first product for the treatment of Hunter syndrome. Idursulfase is a purified form of iduronate-2-sulfase, a 525-amino acid glycoprotein, produced by recombinant DNA technology.
-
Other than water, tea is the most often consumed beverage in the world. Animal studies and in vitro data support the potential role of green tea consumption (GTC) for reducing cardiovascular disease and cancer.
-
The ECG image used in this article was obtained from a previously healthy, middle-aged man with some atypical but new-onset chest discomfort.
-
For hypertensives with coronary artery disease, lowering the diastolic pressure below 70-80 mm Hg appears to create increased risk of morbidity and mortality from myocardial infarction and all-cause death.
-
A team from UCSF recently reviewed company documents that were entered into the public record as a result of litigation over the promotion of gabapentin (Neurontin) between 1994 and 1998.
-
A medical research unit in the United Kingdom analyzed 18 different strategies for managing patients with suspected deep vein thrombosis (DVT). Using systematic review, meta-analysis and cost effectiveness analysis, they settled on an algorithm based on clinical risk.
-
HCV may persist and replicate in the liver and PBMCs of healthy, anti-HCV antibody-positive, serum HCV RNA-negative patients who have persistently normal ALT levels. These patients should be followed up, because they have an ongoing viral infection.
-
Antibiotics may improve acute purulent rhinitis at the cost of gastrointestinal upset and rash.
-
Tight glucose control has been shown to provide improved outcomes in both Type 1 and Type 2 diabetes (DM2).
-
Functional dyspepsia cannot reliably be diagnosed using symptoms alone. Esomeprazole therapy is not effective vs placebo in an 8-week study of endoscopy-negative patients with histories thought to be diagnostic of FD.
